HC Wainwright & Co. Initiates Coverage On ImmunoPrecise Antibodies With Buy Rating, Announces Price Target of $9
HC Wainwright & Co. Initiates Coverage On ImmunoPrecise Antibodies With Buy Rating, Announces Price Target of $9
HC Wainwright&Co.以買入評級推出免疫預抗體覆蓋範圍，宣佈目標價為9美元
HC Wainwright & Co. analyst Swayampakula Ramakanth initiates coverage on ImmunoPrecise Antibodies (NASDAQ:IPA) with a Buy rating and announces Price Target of $9.
HC Wainwright&Co.分析師Swayampakula Ramakanth以買入評級啟動免疫精抗體(納斯達克：IPA)的覆蓋範圍，並宣佈目標價為9美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。